NEO-811 Connecticut Site — New Haven, Connecticut

NEO-811 Connecticut Site is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

NEO-811 Connecticut Site has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma, RCC.

Sponsors: Neomorph, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Haven

Browse all research sites in Connecticut · View every site in New Haven

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEO-811 Connecticut Site?

NEO-811 Connecticut Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEO-811 Connecticut Site conducted?

NEO-811 Connecticut Site has 1 clinical trials on record, with 1 currently active. Their work covers Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma, RCC.

Is NEO-811 Connecticut Site accredited by Crixeo Clinical Trials?

NEO-811 Connecticut Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEO-811 Connecticut Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.